NCT05005806View on ClinicalTrials.gov

Fish Oil (Omega 3 ) in Sjogren's Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 2, 2021

Primary Completion Date

February 1, 2023

Study Completion Date

February 7, 2023

Conditions
Sjogren's Syndrome
Interventions
DRUG

Omega 3 fatty acid

omega 3 fatty acid soft gel

DRUG

Placebo

placebo soft gel

Trial Locations (1)

44001

Reumatology out patient clinic,, Erbil

All Listed Sponsors
lead

Hawler Medical University

OTHER

NCT05005806 - Fish Oil (Omega 3 ) in Sjogren's Syndrome | Biotech Hunter | Biotech Hunter